Enhancing National Covid-19 Screening and Diagnostic Support Capacity in Uganda
Lead Research Organisation:
London School of Hygiene & Tropical Medicine
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The MRC is pleased to confirm additional capital funding for the MRC/UVRI and LSHTM Research Unit Uganda up to the value of £40,000 to procure an Applied Biosystems Real Time PCR machine to support the Centres important work on COVID-19.
This exceptional award is being made in recognition of the fact that research will be critical in overcoming this epidemic.
This exceptional award is being made in recognition of the fact that research will be critical in overcoming this epidemic.
People |
ORCID iD |
Publications
Tegally H
(2022)
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.
in Science (New York, N.Y.)
Omooja J
(2022)
HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting.
in BMC infectious diseases
Nalumansi A
(2021)
Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples.
in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Mugisha J
(2023)
SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.
in Emerging infectious diseases
Lutalo T
(2021)
Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Bbosa N
(2022)
Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021
in Emerging Infectious Diseases
| Description | Guidance to Ministry on which COVID-19 antigen, antibody and PCR kits to use |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| Impact | This has guided on the tests to use during the COVID-19 pandemic and guided private sector which kits to import |
| Description | Collaboration with Ministry of Health |
| Organisation | Ministry of Health, Uganda |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Generation of SARS CoV2 sequence data, policy on vaccine usage |
| Collaborator Contribution | Generation of SARS CoV2 sequence data, policy on vaccine usage |
| Impact | Publications, policy |
| Start Year | 2021 |
| Description | Collaborationwith the Ministry of Health on Research on emerging and re-emeging infections |
| Organisation | Ministry of Health, Uganda |
| Country | Uganda |
| Sector | Public |
| PI Contribution | We are conducting surveillance studies for new and re-ermerging viruses. We look for funding, collaborations and conduct some of the studies locally |
| Collaborator Contribution | The Ministry of Health Departments offer the environment to work in different surveillance sites and some epidemiological expertise |
| Impact | Publications, policies, and valuable samples |
| Start Year | 2016 |